Related Experiment Video
Updated: Jul 8, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Diseases associated with altered ryanodine receptor activity
W J Durham1, X H T Wehrens, S Sood
1Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Mutations in ryanodine receptors (RyR1 and RyR2) cause human skeletal and cardiac diseases. This chapter explores their mechanisms, controversies, and commonalities between muscle types.
Area of Science:
- Molecular Biology
- Human Physiology
- Genetics
Background:
- Intracellular calcium (Ca2+) signaling is crucial for muscle function.
- Ryanodine receptors (RyR1 and RyR2) are key Ca2+ release channels in muscle.
- Dysfunction of RyR channels is linked to various human diseases.
Purpose of the Study:
- To review human skeletal and cardiac diseases caused by RyR1 and RyR2 mutations.
- To discuss the known mechanisms, ongoing controversies, and unanswered questions related to these diseases.
- To compare skeletal and cardiac muscle diseases to identify shared underlying mechanisms.
Main Methods:
- Literature review and synthesis of existing research on RyR mutations and associated diseases.
- Comparative analysis of skeletal and cardiac muscle pathophysiology.
- Discussion of current understanding and future research directions.
Main Results:
- Mutations in RyR1 are primarily associated with skeletal muscle disorders.
- Mutations in RyR2 are primarily associated with cardiac arrhythmias and cardiomyopathies.
- Evidence suggests shared molecular pathways and disease mechanisms between skeletal and cardiac RyR-related disorders.
Conclusions:
- RyR channelopathies represent a significant group of genetic disorders affecting muscle.
- Understanding the specific and common mechanisms of RyR mutations is vital for therapeutic development.
- Further research is needed to resolve controversies and address unanswered questions in the field.
More Related Videos
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Mechanism of Cardiac Arrhythmias
Alterations in Muscle Tone lll
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

